This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Kim SP , Gross CP , Nguyen PL , Smaldone MC , Thompson RH , Shah ND , Kutikov A , Han LC , Karnes RJ , Ziegenfuss JY , Tilburt JC
Specialty bias in treatment recommendations and quality of life among radiation oncologists and urologists for localized prostate cancer
Prostate Cancer Prostatic Dis. 2014 Jun;17(2) :163-9
PMID: 24566445 URL: https://www.ncbi.nlm.nih.gov/pubmed/24566445
AbstractBACKGROUND: Given the importance of physician attitudes about different treatments and the quality of life (QOL) in prostate cancer, we performed a national survey of specialists to assess treatment recommendations and perceptions of treatment-related survival and QOL. METHODS: We mailed a self-administered survey instrument to a random sample of 1366 specialists in the U.S. Respondents were asked for treatment recommendations and survival that varied by PSA levels and Gleason scores and estimate QOL outcomes. Pearson's chi-square and multivariable regression models were used to test for differences in each outcome. RESULTS: Response rates were similar for radiation oncologists (52.6%) and urologists (52.3%; P=0.92). Across all risk strata, urologists were more likely to recommend surgery than were radiation oncologists, for conditions ranging from PSA>20 and Gleason score 8-10 (35.2 vs. 0.2%; P<0.001) to PSA 4-10 and Gleason score 7 (87.5 vs. 20.9%; P<0.001). Radiation oncologists were also more likely to recommend radiation therapy relative to urologists (all P<0.001). From low- to high-risk prostate cancer, radiation oncologists and urologists perceived their treatment as being better for improving survival (all P<0.001). Each specialty also viewed their treatment as having less urinary incontinence (all P<0.001). CONCLUSIONS: Radiation oncologists and urologists both prefer the treatment modalities they offer, perceive them to be more effective and to lead to a better QOL. Patients may be receiving biased information, and a truly informed consent process with shared decision-making may be possible only if they are evaluated by both specialties before deciding upon a treatment course.
NotesKim, S P Gross, C P Nguyen, P L Smaldone, M C Thompson, R H Shah, N D Kutikov, A Han, L C Karnes, R J Ziegenfuss, J Y Tilburt, J C eng Research Support, Non-U.S. Gov't England Prostate Cancer Prostatic Dis. 2014 Jun;17(2):163-9. doi: 10.1038/pcan.2014.3. Epub 2014 Feb 25.